trial · primary record
XB010
Locally Advanced or Metastatic Solid Tumors
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 396 |
| Primary completion | 2027-10-20 |
| Primary endpoint | Dose-Escalation Stage: Maximum tolerated dose (MTD) and/or Recommended dose(s) for Expansion [RDE(s)] for XB010 |
| Registry ID | NCT06545331 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:40:32.027Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06545331
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.